Last updated on February 2019

A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Brief description of study

The objective of this study is to assess the safety of upadacitinib combined with topical corticosteroids (TCS) in adolescent and adult participants in Japan with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

Clinical Study Identifier: NCT03661138

Contact Investigators or Research Sites near you

Start Over

AbbVie GK Clinical Trial Registration ...

Higuchi Dermatology Urology Clinic /ID# 206287
Kasuga-shi, Japan
  Connect »

AbbVie GK Clinical Trial Registration ...

Yasumoto Dermatology Clinic /ID# 206480
Chikushino-shi, Japan
  Connect »

AbbVie GK Clinical Trial Registration ...

Kiryu Dermatology Clinic /ID# 206044
Fukuoka City, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.